- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03802539
5-year Clinical Evaluation of Cavity Lining on the Restoration
January 9, 2019 updated by: Uzay Koc, Hacettepe University
5-year Clinical Evaluation of Cavity Lining on the Restoration of Root Surface Caries Lesions: A Controlled Randomized Clinical Trial
The purpose of this double-blind, randomized trial is to compare the clinical performance of a composite restorations in root surface carious lesions with or without resin modified glass ionomer lining.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Thirty-nine patients with at least one pair of equivalent root caries lesions and a mean age of 39.6 years (range 18-65 years; median 39 years) were enrolled in this study.
After caries removal, the depth, length, and width of the cavity were measured.
Lesions in the same patient was randomly divided into two groups, and the dentin surfaces were either lined with resin-modified glass ionomer liner (Glass liner II, Willmann & Pein GmbH Dental, Barmstedt, Germany) or not.
All cavities were restored with nanohybrid composite resin (Clearfil Majesty Esthetic, Kuraray, Tokyo, Japan).
A total of 100 restorations (50 lined, 50 unlined) were placed according to manufacturer's instructions.
The restorations will be evaluated at baseline and at 6, 12, 24, 36, 48 months and 5-year after placement using the modified Haveman Criteria for marginal adaptation, anatomic form, marginal staining, anatomic form, caries in adjacent tooth structure, caries at the cavosurface margin and sensitivity.
Statistical analysis will be conducted using the Chi- Square, Fisher's Exact, Mann Whitney-U and Cochran Q tests at a significance level of 5% (P < 0.05).
Study Type
Interventional
Enrollment (Actual)
38
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 67 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Non-hospitalized, healthy patients that were seeking dental treatment for caries lesions on the root surface
Exclusion Criteria:
- Patients who were under the age of 18 years
- Complex medical history
- Severe or chronic periodontitis
- Extreme carious activity
- Heavy bruxism
- Very deep or superficial carious lesions
- Previously restored and abutment teeth
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Glass Liner
Tooth restoration with a glass ionomer liner material under a nanohybrid composite resin
|
restoration of root caries according to two different protocols
|
|
No Intervention: No liner
Tooth restoration without a glass ionomer liner material under a nanohybrid composite resin
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Retention Outcome
Time Frame: 5 years
|
1.Retention Alpha for at least 90% of the restorations The primary factor for determining the clinical performance of a restorative material is the retention rate.
It represents the survival rates of the restorations after a period of time.
According to ADA (American Dental Association) guidelines, a restorative material should show at leat 90% alpha retention rate after 18 months to be considered as clinically acceptable.
The retention is assessed as alpha (retentive restoration) or charlie (failed restoration).
Clinical evaluation is performed to examine if the restoration is in place or has fallen.
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2014
Primary Completion (Actual)
July 1, 2016
Study Completion (Anticipated)
January 1, 2020
Study Registration Dates
First Submitted
January 6, 2019
First Submitted That Met QC Criteria
January 9, 2019
First Posted (Actual)
January 14, 2019
Study Record Updates
Last Update Posted (Actual)
January 14, 2019
Last Update Submitted That Met QC Criteria
January 9, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HEK 11/54-8
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Teeth; Lesion
-
Ceren SireNot yet recruiting
-
Universidade IbirapueraCompletedDeep Caries Lesion of Primary TeethBrazil
-
Misr International UniversityNational Research Centre, EgyptActive, not recruitingPatients With Deep Carious Lesions | Deep Carious Lesion | Deep Caries Lesion of Pemanent TeethEgypt
-
Damascus UniversityCompletedPeriapical Lesion | Immature TeethSyrian Arab Republic
-
Malmö UniversityCompletedLow-Dose CBCT Protocol for Pre-Surgical Evaluation of the Mandibular Third Molar, a Feasible Choice?Tooth Diseases | Teeth; LesionSweden
-
University of Alabama at BirminghamCompletedWhite Spot Lesion | Orthodontic Treatment | Decalcification; TeethUnited States
-
Delta University for Science and TechnologyCompletedClinical Comparison Between Stainless-steel Crown, Zirconia Crown and Bioflx Crown in Primary MolarsDecayed Teeth | Carious LesionEgypt
-
Cairo UniversityNot yet recruitingPulpitis | Dental Pulp Diseases | Deep Caries Lesion of Primary Teeth | Decayed Teeth | Reversible Pulpitis | Deep Proximal Caries | Deep Occlusal Caries
-
Mariam Hesham Mahmoud Abdelfattah EissaNot yet recruitingPeriapical Lesion | Root End Resection | Single Rooted Teeth
-
Cairo UniversityUnknownAnterior Teeth | Pulp Necrosis | Periapical Lesion
Clinical Trials on Glass Liner
-
Liberating Technologies, Inc.Vivonics, Inc.CompletedAmputation | Prosthesis | Prosthesis User | Amputation Stumps | Amputees | Lower Limb Deformities, CongenitalUnited States
-
GI DynamicsCompleted
-
Pearl NetworkNational Institute of Dental and Craniofacial Research (NIDCR)CompletedDental CariesUnited States
-
GI DynamicsCompleted
-
VA Puget Sound Health Care SystemActive, not recruitingAmputation | Prosthesis UserUnited States
-
Biomet Nederland BVAtrium Medical CenterTerminatedOsteoarthritisNetherlands
-
Liberating Technologies, Inc.Vivonics, Inc.TerminatedAmputation | Prosthesis | Prosthesis User | Amputation Stump | Amputees | Lower Limb DeformityUnited States
-
Goeran FiedlerUnited States Department of Defense; Widener UniversityTerminatedSkin Diseases | Artificial LimbsUnited States
-
GI DynamicsCompletedObesity | Type 2 DiabetesUnited Kingdom